Turning novel concepts into realities

Neurology Pipeline

Turning novel concepts into realities

Our current pipeline includes clinical and preclinical trials to investigate novel treatments in a variety of medical conditions.

NOTE: clicking on a highlighted drug code will send you to the current clinical trial on clinicaltrails.gov.

Proof-of-Concept Phase – II Phase – III NDA-filed Approved Launched
ZEMBRACE® SymTouch®
(sumatriptan injection) 3 mgLaunched
TOSYMRA™
(sumatriptan nasal spray)
Approved
DFN-15
Oral Liquid CelecoxibPHASE III
DFN-19
DHE Nasal SprayProof-of-concept
Parkinson’s Disease*
Epilepsy*
*Multiple ongoing programs